Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

tumor volume

  • SPECT/CT in Early Response Assessment of Patients with Metastatic Castration-Resistant Prostate Cancer Receiving <sup>177</sup>Lu-PSMA-617
    You have access
    SPECT/CT in Early Response Assessment of Patients with Metastatic Castration-Resistant Prostate Cancer Receiving 177Lu-PSMA-617
    Ridvan Arda Demirci, Roman Gulati, Jessica E. Hawley, Todd Yezefski, Michael C. Haffner, Heather H. Cheng, Robert B. Montgomery, Michael T. Schweizer, Evan Y. Yu, Peter S. Nelson, Delphine L. Chen and Amir Iravani
    Journal of Nuclear Medicine December 1, 2024, 65 (12) 1945-1951; DOI: https://doi.org/10.2967/jnumed.124.267665
  • [<sup>18</sup>F]FDG PET/CT–Avid Discordant Volume as a Biomarker in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Study
    Open Access
    [18F]FDG PET/CT–Avid Discordant Volume as a Biomarker in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Study
    David L. Chan, Aimee R. Hayes, Ioannis Karfis, Alice Conner, Magdalena Mileva, Elizabeth Bernard, Geoffrey Schembri, Shaunak Navalkissoor, Gopinath Gnanasegaran, Nick Pavlakis, Clémentine Marin, Bruno Vanderlinden, Patrick Flamen, Paul Roach, Martyn E. Caplin, Christos Toumpanakis and Dale L. Bailey
    Journal of Nuclear Medicine February 1, 2024, 65 (2) 185-191; DOI: https://doi.org/10.2967/jnumed.123.266346
  • 
    Repeatability of <sup>68</sup>Ga-PSMA-HBED-CC PET/CT–Derived Total Molecular Tumor Volume
    You have access
    Repeatability of 68Ga-PSMA-HBED-CC PET/CT–Derived Total Molecular Tumor Volume
    Robert Seifert, Patrick Sandach, David Kersting, Wolfgang P. Fendler, Boris Hadaschik, Ken Herrmann, John J. Sunderland and Janet H. Pollard
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 746-753; DOI: https://doi.org/10.2967/jnumed.121.262528
  • Semiautomatically Quantified Tumor Volume Using <sup>68</sup>Ga-PSMA-11 PET as a Biomarker for Survival in Patients with Advanced Prostate Cancer
    You have access
    Semiautomatically Quantified Tumor Volume Using 68Ga-PSMA-11 PET as a Biomarker for Survival in Patients with Advanced Prostate Cancer
    Robert Seifert, Ken Herrmann, Jens Kleesiek, Michael Schäfers, Vijay Shah, Zhoubing Xu, Guillaume Chabin, Sasa Grbic, Bruce Spottiswoode and Kambiz Rahbar
    Journal of Nuclear Medicine December 1, 2020, 61 (12) 1786-1792; DOI: https://doi.org/10.2967/jnumed.120.242057
  • You have access
    Initial Experience with Volumetric 68Ga-PSMA I&T PET/CT for Assessment of Whole-Body Tumor Burden as a Quantitative Imaging Biomarker in Patients with Prostate Cancer
    Sebastian Schmuck, Christoph A. von Klot, Christoph Henkenberens, Jan M. Sohns, Hans Christiansen, Hans-Jürgen Wester, Tobias L. Ross, Frank M. Bengel and Thorsten Derlin
    Journal of Nuclear Medicine December 1, 2017, 58 (12) 1962-1968; DOI: https://doi.org/10.2967/jnumed.117.193581
  • You have access
    Prediction of PSA Progression in Castration-Resistant Prostate Cancer Based on Treatment-Associated Change in Tumor Burden Quantified by 18F-Fluorocholine PET/CT
    Joohee Lee, Miles M. Sato, Marc N. Coel, Kyung-Han Lee and Sandi A. Kwee
    Journal of Nuclear Medicine July 1, 2016, 57 (7) 1058-1064; DOI: https://doi.org/10.2967/jnumed.115.169177
  • You have access
    Estimation of Tumor Volumes by 11C-MeAIB and 18F-FDG PET in an Orthotopic Glioblastoma Rat Model
    Bo Halle, Helge Thisgaard, Svend Hvidsten, Johan H. Dam, Charlotte Aaberg-Jessen, Anne S. Thykjær, Poul F. Høilund-Carlsen, Mette K. Schulz, Claus Andersen and Bjarne W. Kristensen
    Journal of Nuclear Medicine October 1, 2015, 56 (10) 1562-1568; DOI: https://doi.org/10.2967/jnumed.115.162511
  • You have access
    Predictive Value of Early-Stage Uptake of 3′-Deoxy-3′-18F-Fluorothymidine in Cancer Cells Treated with Charged Particle Irradiation
    Chao Lin, Kyo Kume, Tetsuya Mori, Miguel E. Martinez, Hidehiko Okazawa and Yasushi Kiyono
    Journal of Nuclear Medicine June 1, 2015, 56 (6) 945-950; DOI: https://doi.org/10.2967/jnumed.114.152983
SNMMI

© 2025 SNMMI

Powered by HighWire